Compound B as angiogenic agent in combination with human...

Details Compound B as angiogenic agent in combination with human... Compound B as angiogenic agent in combination with human...

2005-02-15

2005-02-15

Weber, Jon (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C530S350000, C530S399000

Reexamination Certificate

active

06855684

ABSTRACT:
The present invention refers to the use of Compound B as angiogenic agent in combination with human growth factors.

REFERENCES:
patent: 5998364 (1999-12-01), Borrelli et al.
patent: 94 14959 (1994-07-01), None
patent: 97 39765 (1997-10-01), None
Folkman, “Clinical Application of Research on Angiogenesis”,Seminars in Medicine of the Beth Israel Hospital, Boston, vol. 333, No. 26, pp. 1757-1763, Dec. 29, 1995.

Affiliated with

Also associated with

Rating

Compound B as angiogenic agent in combination with human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compound B as angiogenic agent in combination with human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound B as angiogenic agent in combination with human... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3506667